Eur Heart J:计算机断层扫描冠状动脉造影获得的血流储备分数在稳定型胸痛评估中的价值

2021-07-19 MedSci原创 MedSci原创

对于稳定型心绞痛患者进行选择性FFRCT获得CTCA的策略在成本或临床结局方面与标准临床处理途径没有显著差异,但确实减少了有创冠状动脉造影的使用程度。

使用计算机断层扫描冠状动脉造影 (CTCA) 获得的血流储备分数 (FFRCT) 可确定冠状动脉疾病和血管特异性缺血。

近日,心血管领域权威杂志Eur Heart J上发表了一篇研究文章,研究人员评估了基于FFRCT的评估策略与标准处理相比是否会改善经济和临床结局。

总体而言,11个中心的1400名稳定型胸痛患者随机接受CTCA和选择性FFRCT实验组)或标准临床处理途径(标准组)。该研究的主要终点是9个月时的心脏总费用;次要终点是心绞痛状态、生活质量、主要不良心脑血管事件以及有创冠状动脉造影的使用情况。

随机分组的患者在基线时相似。大多数患者进行了CTCA检查:标准组439例(63%)与实验组674例(96%),其中 254例(38%) 接受了FFRCT检查。实验组的平均心脏总费用高出114英镑(+8%),95%置信区间从-112(-8%)到+337(+23%),但差异不显著(P=0.10)。主要不良心脏和脑血管事件没有显著差异(实验组为10.2%,标准组为10.6%),并且两个组的心绞痛和生活质量在随访期间的改善程度相似。实验组有创血管造影显著减少(19% vs. 25%,P=0.01)。

由此可见,对于稳定型心绞痛患者进行选择性FFRCT获得CTCA的策略在成本或临床结局方面与标准临床处理途径没有显著差异,但确实减少了有创冠状动脉造影的使用程度。

原始出处:

N Curzen.et al.Fractional flow reserve derived from computed tomography coronary angiography in the assessment and management of stable chest pain: the FORECAST randomized trial.European Heart Journal.2021.https://doi.org/10.1093/eurheartj/ehab444

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1803377, encodeId=fcf618033e758, content=<a href='/topic/show?id=8b44e528972' target=_blank style='color:#2F92EE;'>#稳定型#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=75289, encryptionId=8b44e528972, topicName=稳定型)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18b32500069, createdName=108807375_62823127, createdTime=Sun Oct 24 19:33:51 CST 2021, time=2021-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1716423, encodeId=df6c1e1642343, content=<a href='/topic/show?id=d68d911542f' target=_blank style='color:#2F92EE;'>#计算机#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91154, encryptionId=d68d911542f, topicName=计算机)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=def632217870, createdName=bioon14, createdTime=Fri Apr 22 17:33:51 CST 2022, time=2022-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1357745, encodeId=38a3135e74586, content=<a href='/topic/show?id=b0702e84b9' target=_blank style='color:#2F92EE;'>#ART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2784, encryptionId=b0702e84b9, topicName=ART)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Wed Jul 21 13:33:51 CST 2021, time=2021-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1447161, encodeId=8898144e161d3, content=<a href='/topic/show?id=97e1309105d' target=_blank style='color:#2F92EE;'>#冠状动脉造影#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30910, encryptionId=97e1309105d, topicName=冠状动脉造影)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/RNJfsfhsEic2avjCncr2VWPKViaUUV8QbHGvDicvYf6AiaQxTlhBo1TZBFuZQq80ia2pejj3QwjOy03Hyt1z1b3DQpA/132, createdBy=2e4c5322318, createdName=mhzhuang@stu.e, createdTime=Wed Jul 21 13:33:51 CST 2021, time=2021-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1494178, encodeId=dc1e14941e80a, content=<a href='/topic/show?id=3e34949e333' target=_blank style='color:#2F92EE;'>#造影#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94973, encryptionId=3e34949e333, topicName=造影)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=908d9134595, createdName=sodoo, createdTime=Wed Jul 21 13:33:51 CST 2021, time=2021-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1563492, encodeId=1ac31563492d5, content=<a href='/topic/show?id=f69d864413' target=_blank style='color:#2F92EE;'>#HEART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8644, encryptionId=f69d864413, topicName=HEART)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80d715270048, createdName=slcumt, createdTime=Wed Jul 21 13:33:51 CST 2021, time=2021-07-21, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1803377, encodeId=fcf618033e758, content=<a href='/topic/show?id=8b44e528972' target=_blank style='color:#2F92EE;'>#稳定型#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=75289, encryptionId=8b44e528972, topicName=稳定型)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18b32500069, createdName=108807375_62823127, createdTime=Sun Oct 24 19:33:51 CST 2021, time=2021-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1716423, encodeId=df6c1e1642343, content=<a href='/topic/show?id=d68d911542f' target=_blank style='color:#2F92EE;'>#计算机#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91154, encryptionId=d68d911542f, topicName=计算机)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=def632217870, createdName=bioon14, createdTime=Fri Apr 22 17:33:51 CST 2022, time=2022-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1357745, encodeId=38a3135e74586, content=<a href='/topic/show?id=b0702e84b9' target=_blank style='color:#2F92EE;'>#ART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2784, encryptionId=b0702e84b9, topicName=ART)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Wed Jul 21 13:33:51 CST 2021, time=2021-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1447161, encodeId=8898144e161d3, content=<a href='/topic/show?id=97e1309105d' target=_blank style='color:#2F92EE;'>#冠状动脉造影#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30910, encryptionId=97e1309105d, topicName=冠状动脉造影)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/RNJfsfhsEic2avjCncr2VWPKViaUUV8QbHGvDicvYf6AiaQxTlhBo1TZBFuZQq80ia2pejj3QwjOy03Hyt1z1b3DQpA/132, createdBy=2e4c5322318, createdName=mhzhuang@stu.e, createdTime=Wed Jul 21 13:33:51 CST 2021, time=2021-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1494178, encodeId=dc1e14941e80a, content=<a href='/topic/show?id=3e34949e333' target=_blank style='color:#2F92EE;'>#造影#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94973, encryptionId=3e34949e333, topicName=造影)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=908d9134595, createdName=sodoo, createdTime=Wed Jul 21 13:33:51 CST 2021, time=2021-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1563492, encodeId=1ac31563492d5, content=<a href='/topic/show?id=f69d864413' target=_blank style='color:#2F92EE;'>#HEART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8644, encryptionId=f69d864413, topicName=HEART)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80d715270048, createdName=slcumt, createdTime=Wed Jul 21 13:33:51 CST 2021, time=2021-07-21, status=1, ipAttribution=)]
    2022-04-22 bioon14
  3. [GetPortalCommentsPageByObjectIdResponse(id=1803377, encodeId=fcf618033e758, content=<a href='/topic/show?id=8b44e528972' target=_blank style='color:#2F92EE;'>#稳定型#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=75289, encryptionId=8b44e528972, topicName=稳定型)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18b32500069, createdName=108807375_62823127, createdTime=Sun Oct 24 19:33:51 CST 2021, time=2021-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1716423, encodeId=df6c1e1642343, content=<a href='/topic/show?id=d68d911542f' target=_blank style='color:#2F92EE;'>#计算机#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91154, encryptionId=d68d911542f, topicName=计算机)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=def632217870, createdName=bioon14, createdTime=Fri Apr 22 17:33:51 CST 2022, time=2022-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1357745, encodeId=38a3135e74586, content=<a href='/topic/show?id=b0702e84b9' target=_blank style='color:#2F92EE;'>#ART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2784, encryptionId=b0702e84b9, topicName=ART)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Wed Jul 21 13:33:51 CST 2021, time=2021-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1447161, encodeId=8898144e161d3, content=<a href='/topic/show?id=97e1309105d' target=_blank style='color:#2F92EE;'>#冠状动脉造影#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30910, encryptionId=97e1309105d, topicName=冠状动脉造影)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/RNJfsfhsEic2avjCncr2VWPKViaUUV8QbHGvDicvYf6AiaQxTlhBo1TZBFuZQq80ia2pejj3QwjOy03Hyt1z1b3DQpA/132, createdBy=2e4c5322318, createdName=mhzhuang@stu.e, createdTime=Wed Jul 21 13:33:51 CST 2021, time=2021-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1494178, encodeId=dc1e14941e80a, content=<a href='/topic/show?id=3e34949e333' target=_blank style='color:#2F92EE;'>#造影#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94973, encryptionId=3e34949e333, topicName=造影)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=908d9134595, createdName=sodoo, createdTime=Wed Jul 21 13:33:51 CST 2021, time=2021-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1563492, encodeId=1ac31563492d5, content=<a href='/topic/show?id=f69d864413' target=_blank style='color:#2F92EE;'>#HEART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8644, encryptionId=f69d864413, topicName=HEART)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80d715270048, createdName=slcumt, createdTime=Wed Jul 21 13:33:51 CST 2021, time=2021-07-21, status=1, ipAttribution=)]
    2021-07-21 zhaojie88
  4. [GetPortalCommentsPageByObjectIdResponse(id=1803377, encodeId=fcf618033e758, content=<a href='/topic/show?id=8b44e528972' target=_blank style='color:#2F92EE;'>#稳定型#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=75289, encryptionId=8b44e528972, topicName=稳定型)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18b32500069, createdName=108807375_62823127, createdTime=Sun Oct 24 19:33:51 CST 2021, time=2021-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1716423, encodeId=df6c1e1642343, content=<a href='/topic/show?id=d68d911542f' target=_blank style='color:#2F92EE;'>#计算机#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91154, encryptionId=d68d911542f, topicName=计算机)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=def632217870, createdName=bioon14, createdTime=Fri Apr 22 17:33:51 CST 2022, time=2022-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1357745, encodeId=38a3135e74586, content=<a href='/topic/show?id=b0702e84b9' target=_blank style='color:#2F92EE;'>#ART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2784, encryptionId=b0702e84b9, topicName=ART)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Wed Jul 21 13:33:51 CST 2021, time=2021-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1447161, encodeId=8898144e161d3, content=<a href='/topic/show?id=97e1309105d' target=_blank style='color:#2F92EE;'>#冠状动脉造影#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30910, encryptionId=97e1309105d, topicName=冠状动脉造影)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/RNJfsfhsEic2avjCncr2VWPKViaUUV8QbHGvDicvYf6AiaQxTlhBo1TZBFuZQq80ia2pejj3QwjOy03Hyt1z1b3DQpA/132, createdBy=2e4c5322318, createdName=mhzhuang@stu.e, createdTime=Wed Jul 21 13:33:51 CST 2021, time=2021-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1494178, encodeId=dc1e14941e80a, content=<a href='/topic/show?id=3e34949e333' target=_blank style='color:#2F92EE;'>#造影#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94973, encryptionId=3e34949e333, topicName=造影)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=908d9134595, createdName=sodoo, createdTime=Wed Jul 21 13:33:51 CST 2021, time=2021-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1563492, encodeId=1ac31563492d5, content=<a href='/topic/show?id=f69d864413' target=_blank style='color:#2F92EE;'>#HEART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8644, encryptionId=f69d864413, topicName=HEART)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80d715270048, createdName=slcumt, createdTime=Wed Jul 21 13:33:51 CST 2021, time=2021-07-21, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1803377, encodeId=fcf618033e758, content=<a href='/topic/show?id=8b44e528972' target=_blank style='color:#2F92EE;'>#稳定型#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=75289, encryptionId=8b44e528972, topicName=稳定型)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18b32500069, createdName=108807375_62823127, createdTime=Sun Oct 24 19:33:51 CST 2021, time=2021-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1716423, encodeId=df6c1e1642343, content=<a href='/topic/show?id=d68d911542f' target=_blank style='color:#2F92EE;'>#计算机#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91154, encryptionId=d68d911542f, topicName=计算机)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=def632217870, createdName=bioon14, createdTime=Fri Apr 22 17:33:51 CST 2022, time=2022-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1357745, encodeId=38a3135e74586, content=<a href='/topic/show?id=b0702e84b9' target=_blank style='color:#2F92EE;'>#ART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2784, encryptionId=b0702e84b9, topicName=ART)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Wed Jul 21 13:33:51 CST 2021, time=2021-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1447161, encodeId=8898144e161d3, content=<a href='/topic/show?id=97e1309105d' target=_blank style='color:#2F92EE;'>#冠状动脉造影#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30910, encryptionId=97e1309105d, topicName=冠状动脉造影)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/RNJfsfhsEic2avjCncr2VWPKViaUUV8QbHGvDicvYf6AiaQxTlhBo1TZBFuZQq80ia2pejj3QwjOy03Hyt1z1b3DQpA/132, createdBy=2e4c5322318, createdName=mhzhuang@stu.e, createdTime=Wed Jul 21 13:33:51 CST 2021, time=2021-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1494178, encodeId=dc1e14941e80a, content=<a href='/topic/show?id=3e34949e333' target=_blank style='color:#2F92EE;'>#造影#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94973, encryptionId=3e34949e333, topicName=造影)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=908d9134595, createdName=sodoo, createdTime=Wed Jul 21 13:33:51 CST 2021, time=2021-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1563492, encodeId=1ac31563492d5, content=<a href='/topic/show?id=f69d864413' target=_blank style='color:#2F92EE;'>#HEART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8644, encryptionId=f69d864413, topicName=HEART)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80d715270048, createdName=slcumt, createdTime=Wed Jul 21 13:33:51 CST 2021, time=2021-07-21, status=1, ipAttribution=)]
    2021-07-21 sodoo
  6. [GetPortalCommentsPageByObjectIdResponse(id=1803377, encodeId=fcf618033e758, content=<a href='/topic/show?id=8b44e528972' target=_blank style='color:#2F92EE;'>#稳定型#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=75289, encryptionId=8b44e528972, topicName=稳定型)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18b32500069, createdName=108807375_62823127, createdTime=Sun Oct 24 19:33:51 CST 2021, time=2021-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1716423, encodeId=df6c1e1642343, content=<a href='/topic/show?id=d68d911542f' target=_blank style='color:#2F92EE;'>#计算机#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91154, encryptionId=d68d911542f, topicName=计算机)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=def632217870, createdName=bioon14, createdTime=Fri Apr 22 17:33:51 CST 2022, time=2022-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1357745, encodeId=38a3135e74586, content=<a href='/topic/show?id=b0702e84b9' target=_blank style='color:#2F92EE;'>#ART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2784, encryptionId=b0702e84b9, topicName=ART)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Wed Jul 21 13:33:51 CST 2021, time=2021-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1447161, encodeId=8898144e161d3, content=<a href='/topic/show?id=97e1309105d' target=_blank style='color:#2F92EE;'>#冠状动脉造影#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30910, encryptionId=97e1309105d, topicName=冠状动脉造影)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/RNJfsfhsEic2avjCncr2VWPKViaUUV8QbHGvDicvYf6AiaQxTlhBo1TZBFuZQq80ia2pejj3QwjOy03Hyt1z1b3DQpA/132, createdBy=2e4c5322318, createdName=mhzhuang@stu.e, createdTime=Wed Jul 21 13:33:51 CST 2021, time=2021-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1494178, encodeId=dc1e14941e80a, content=<a href='/topic/show?id=3e34949e333' target=_blank style='color:#2F92EE;'>#造影#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94973, encryptionId=3e34949e333, topicName=造影)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=908d9134595, createdName=sodoo, createdTime=Wed Jul 21 13:33:51 CST 2021, time=2021-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1563492, encodeId=1ac31563492d5, content=<a href='/topic/show?id=f69d864413' target=_blank style='color:#2F92EE;'>#HEART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8644, encryptionId=f69d864413, topicName=HEART)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80d715270048, createdName=slcumt, createdTime=Wed Jul 21 13:33:51 CST 2021, time=2021-07-21, status=1, ipAttribution=)]
    2021-07-21 slcumt

相关资讯

Circ Cardiovasc Inte:支架置入术后的影像学和生理学评估

使用血流储备分数(FFR)或瞬时无波率进行侵入性生理评估已成为定义缺血所致冠状动脉狭窄和指导冠状动脉疾病患者进行血运重建策略的标准方法。此外,既往研究已表明,支架置入术后患者的FFR值会影响预后效果。即使造影显示支架置入成功,目标血管残留病变、支架扩张不充分或支架相关并发症如边缘剥离等,仍会造成FFR较低。临床医生如何应对上述局面,近期《循环:心血管介入杂志》(Circulation: Cardi

JAHA:经导管主动脉瓣植入心肌血运重建的生理vs.血管造影引导

在这项观察性研究中,FFR引导与经导管主动脉瓣植入患者较好的预后相关。

Circ-Cardiovasc Int:FFR指导的搭桥手术可大幅降低死亡风险

根据《循环·心血管介入》杂志发表的研究结果,与传统冠脉造影指导的冠状动脉旁路移植术相比,血流储备分数(FFR)指导的冠状动脉旁路移植术能显著降低总死亡率或心肌梗死发生率。

JAHA:FFR vs. OCT 冠状动脉病变如何选择造影术

血流储备分数(FFR)和光学相干断层扫描术(OCT)对冠状动脉造影中病变的评估和经皮冠状动脉介入治疗的优化均有帮助。近期发表于《美国心脏协会杂志》(Journal of the American Heart Association)的一篇研究对此设计了一项前瞻性试验,比较FFR或OCT在冠状动脉病变造影中的临床价值和经济效果。

JACC:血流储备分数在稳定缺血性心脏病患者中的应用价值

血流储备分数(FFR)在稳定缺血性心脏病(SIHD)中的测量和对预后的预测尚存争议。本研究的目的旨在评估FFR在现实世界中SIHD患者的预后预测中的应用。本研究纳入分析了来自66个医学中心的17989名经冠脉造影证实的SIHD患者,在轻中度病变的患者中,FFR的范围为14.8%-18.5%,而接受经皮冠脉介入治疗患者的FFR范围为44%-75%。FFR指导下的治疗患者的1年死亡率为2.8%,而仅由

JACC:严重主动脉瓣狭窄和冠脉疾病患者TAVR术后的冠脉血流动力学

TAVR术后收缩期和充血冠脉血流显著增加。